تخطَّ إلى المحتوى
دليل الأدوية المصري
تابع آخر تحديثات الأسعار على واتساب

معلومات الدواء

التفاصيل الكاملة
عن الدواءAbout the medicine

Ritalin (methylphenidate) 10 mg tablets, pack of 30; listed in Egypt under Novartis with the Egyptian Pharmaceutical Trading Company; the original sheet name marks it (n/a), suggesting limited availability.

Ritalin (methylphenidate) 10 mg tablets, pack of 30; listed in Egypt under Novartis with the Egyptian Pharmaceutical Trading Company; the original sheet name marks it (n/a), suggesting limited availability.

دواعي الاستعمالUses
  • Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older and adults.DailyMed (NLM)
  • Narcolepsy.DailyMed (NLM)
  • Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older and adults.DailyMed (NLM)
  • Narcolepsy.DailyMed (NLM)
موانع الاستعمالContraindications
  • Hypersensitivity to methylphenidate or other components.نشرة دولية لنفس المنتج · DailyMed (NLM)
  • Concomitant MAOI use or within 14 days after stopping an MAOI (risk of hypertensive crisis).نشرة دولية لنفس المنتج · DailyMed (NLM)
  • Hypersensitivity to methylphenidate or other components.International label, same product · DailyMed (NLM)
  • Concomitant MAOI use or within 14 days after stopping an MAOI (risk of hypertensive crisis).International label, same product · DailyMed (NLM)
تحذيرات واحتياطاتWarnings & precautions
  • Boxed warning: high potential for abuse and misuse that can lead to substance use disorder including addiction; assess risk before and during treatment.نشرة دولية لنفس المنتج · DailyMed (NLM)
  • Avoid in known serious structural cardiac abnormalities, cardiomyopathy, serious arrhythmia or coronary artery disease (sudden death reported); monitor blood pressure and heart rate; screen for mania risk; priapism and peripheral vasculopathy reported.نشرة دولية لنفس المنتج · DailyMed (NLM)
  • Boxed warning: high potential for abuse and misuse that can lead to substance use disorder including addiction; assess risk before and during treatment.International label, same product · DailyMed (NLM)
  • Avoid in known serious structural cardiac abnormalities, cardiomyopathy, serious arrhythmia or coronary artery disease (sudden death reported); monitor blood pressure and heart rate; screen for mania risk; priapism and peripheral vasculopathy reported.International label, same product · DailyMed (NLM)
التداخلات الدوائيةDrug interactions
  • Monoamine oxidase inhibitorsContraindicated together or within 14 days (hypertensive crisis).DailyMed (NLM)
  • Monoamine oxidase inhibitorsContraindicated together or within 14 days (hypertensive crisis).DailyMed (NLM)
الحمل والرضاعةPregnancy & breastfeeding
  • Published studies and postmarketing reports have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal/fetal outcomes; possible fetal risks from CNS stimulant use; registry available.نشرة دولية لنفس المنتج · DailyMed (NLM)
  • Methylphenidate is present in human milk (infant dose 0.16-0.7% of maternal weight-adjusted dose); no adverse effects in breastfed infants reported.نشرة دولية لنفس المنتج · DailyMed (NLM)
  • Published studies and postmarketing reports have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal/fetal outcomes; possible fetal risks from CNS stimulant use; registry available.International label, same product · DailyMed (NLM)
  • Methylphenidate is present in human milk (infant dose 0.16-0.7% of maternal weight-adjusted dose); no adverse effects in breastfed infants reported.International label, same product · DailyMed (NLM)
كيف يعمل الدواءHow it works
  • ميثيلفينيديت: يمنع إعادة امتصاص النورإبينفرين والدوبامين ويزيد إطلاقهما.منبه للجهاز العصبي المركزي
  • Methylphenidate: Blocks reuptake of norepinephrine and dopamine into the presynaptic neuron and increases their release into the extraneuronal space.

المصادر

  • السعر: قوائم أسعار الأدوية المنشورة في مصر.
  • DailyMed (NLM)

تعليقات

لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.

أضف تعليقًا

0/60

لا يُنشر أبدًا؛ للتواصل فقط إن لزم.

0/1000

من 20 إلى 1000 حرف. بدون روابط.

التعليقات للمعلومات العامة ولا تُعد نصيحة طبية. لا تذكر بيانات شخصية.